Treatment of premature ejaculation and comorbid endocrine and metabolic disorders

2Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Recent evidence has pointed out the possibility that gonadal, thyroid and pituitary hormones (oxytocin and prolactin) might be involved in the control of the ejaculatory process and its overall latency time, along with all other aspects of the male reproduction system. Restoring euthyroidism, in hyperthyroidism-associated premature ejaculation can improve ejaculatory latency, although a limited number of subjects has been evaluated so far. Hypogonadism and hypothyroidism might be associated with delayed ejaculation and in the latter case, improvement of intravaginal ejaculation latency time has been reported only after correcting the hypothyroidism. Larger and longer studies are advisable in order to better clarify these points.

Cite

CITATION STYLE

APA

Corona, G., Rastrelli, G., & Maggi, M. (2013). Treatment of premature ejaculation and comorbid endocrine and metabolic disorders. In Premature Ejaculation: From Etiology to Diagnosis and Treatment (pp. 289–303). Springer-Verlag Italia s.r.l. https://doi.org/10.1007/978-88-470-2646-9_23

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free